News Release 2009

November 5, 2009Execution of License Agreement on Neramexane for Tinnitus with Merz Pharmaceuticals for Japan Territory
September 29, 2009KYORIN and Eisai Sign License Agreement for Development and Marketing of Uritos® Tablets in China, India, Sri Lanka and ASEAN Countries
August 5, 2009First Quarter Consolidated Financial Results for the Fiscal Year Ending March 31, 2010
July 27, 2009Grant of Marketing Right to Senju Pharmaceutical on Gatifloxacin Ophthalmic Solution in China
April 3, 2009Change of Representative Director and President at KYORIN Pharmaceutical
April 3, 2009Change of Representative Director and President at KYORIN
March 19, 2009KYORIN Announces Dissolution of Subsidiary
March 19, 2009KYORIN Subsidiary (Investment LPS) to Be Dissolved
February 27, 2009Execution of Licensing and Supply Agreement on Uritos® Tablets with SPIMACO
February 5, 2009Third Quarter Consolidated Financial Results for the Fiscal Year Ending March 31, 2009
February 4, 2009KYORIN Updates Credit Rating from R&I
January 29, 2009Paper on Clinical Trial of MUCODYNE® for COPD Patients (PEACE Study) Chosen for THE LANCET Paper of the Year 2008